TW201000115A - IQGAP3 epitope peptides and vaccines containing the same - Google Patents

IQGAP3 epitope peptides and vaccines containing the same Download PDF

Info

Publication number
TW201000115A
TW201000115A TW098119196A TW98119196A TW201000115A TW 201000115 A TW201000115 A TW 201000115A TW 098119196 A TW098119196 A TW 098119196A TW 98119196 A TW98119196 A TW 98119196A TW 201000115 A TW201000115 A TW 201000115A
Authority
TW
Taiwan
Prior art keywords
leu
ala
iqgap3
peptide
sequence
Prior art date
Application number
TW098119196A
Other languages
English (en)
Chinese (zh)
Inventor
Takuya Tsunoda
Ryuji Ohsawa
Sachiko Yoshimura
Tomohisa Watanabe
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of TW201000115A publication Critical patent/TW201000115A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW098119196A 2008-06-11 2009-06-09 IQGAP3 epitope peptides and vaccines containing the same TW201000115A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6053808P 2008-06-11 2008-06-11

Publications (1)

Publication Number Publication Date
TW201000115A true TW201000115A (en) 2010-01-01

Family

ID=41416549

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098119196A TW201000115A (en) 2008-06-11 2009-06-09 IQGAP3 epitope peptides and vaccines containing the same

Country Status (13)

Country Link
US (1) US20110200626A1 (enExample)
EP (1) EP2303909A4 (enExample)
JP (1) JP2011523937A (enExample)
KR (1) KR20110036903A (enExample)
CN (1) CN102119169A (enExample)
AU (1) AU2009258788A1 (enExample)
BR (1) BRPI0915527A2 (enExample)
CA (1) CA2727485A1 (enExample)
IL (1) IL209869A0 (enExample)
MX (1) MX2010013680A (enExample)
RU (1) RU2010154081A (enExample)
TW (1) TW201000115A (enExample)
WO (1) WO2009150835A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI543767B (zh) 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Hig2與urlc10抗原決定位胜肽以及含此胜肽之疫苗
TW201134480A (en) * 2010-04-08 2011-10-16 Oncotherapy Science Inc CLUAP1 peptides and vaccines including the same
IL292864A (en) 2015-08-28 2022-07-01 Immatics Biotechnologies Gmbh New peptides and a combination of peptides and supports for use in immunotherapy in certain types of cancer
GB201515321D0 (en) * 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
JP6977150B2 (ja) 2017-04-26 2021-12-08 ジーブイエス フィルトレイション,インコーポレイテッド 複合ビードエアフィルタシール
CN112521455B (zh) * 2020-12-08 2022-09-02 长春理工大学 一种检测膀胱癌抗原蛋白特异性的多肽及其应用
CN118930633A (zh) * 2023-05-12 2024-11-12 中国科学院深圳先进技术研究院 肿瘤相关抗原表位肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
US7998695B2 (en) * 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP1907582B1 (en) * 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer

Also Published As

Publication number Publication date
US20110200626A1 (en) 2011-08-18
JP2011523937A (ja) 2011-08-25
EP2303909A4 (en) 2012-10-31
WO2009150835A1 (en) 2009-12-17
IL209869A0 (en) 2011-02-28
BRPI0915527A2 (pt) 2016-01-26
RU2010154081A (ru) 2012-07-20
EP2303909A1 (en) 2011-04-06
CA2727485A1 (en) 2009-12-17
MX2010013680A (es) 2011-02-23
KR20110036903A (ko) 2011-04-12
AU2009258788A1 (en) 2009-12-17
CN102119169A (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
TWI434853B (zh) 腫瘤血管內皮標誌8胜肽及包含此胜肽之疫苗
CN102119171B (zh) Cdca1表位肽及包含它的疫苗
US8617562B2 (en) FOXM1 peptides and immunogenic compositions containing them
TW201008574A (en) INHBB epitope peptides and vaccines containing the same
AU2009283763B2 (en) HIG2 and URLC10 epitope peptide and vaccines containing the same
US20110200626A1 (en) Iqgap3 epitope peptides and vaccines containing the same
US8563516B2 (en) Foxp3 peptide vaccine
TW201000119A (en) MYBL2 epitope peptides and vaccines containing the same
TWI466680B (zh) Melk抗原決定位胜肽及含此胜肽的疫苗
US20140199335A1 (en) C1orf59 peptides and vaccines including the same
TW201019953A (en) RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
US9745343B2 (en) Method of inducing an immune response by administering WDRPUH epitope peptides
AU2010216980B2 (en) FOXM1 peptides and vaccines containing the same